Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Chemerin is a novel adipokine associated with obesity and metabolic syndrome.

Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Abstract Text:

    kiymet bozaogluKiymet Bozaoglu,kristy boltonKristy Bolton,janine mcmillanJanine McMillan,paul zimmetPaul Zimmet,jeremy jowettJeremy Jowett,greg collierGreg Collier,ken walderKen Walder,david segalDavid Segal,

    Soluble protein hormones are key regulators of a number of metabolic processes, including food intake and insulin sensitivity. We have used a signal sequence trap to identify genes that encode secreted or membrane-bound proteins in Psammomys obesus, an animal model of obesity and type 2 diabetes (T2D). Using this signal sequence trap, we identified the chemokine chemerin as being a novel adipokine. Gene expression of chemerin and its receptor, chemokine-like receptor 1 (CMKLR1), was significantly higher in adipose tissue of obese and type 2 diabetic P. obesus compared with lean, normoglycemic P. obesus. Fractionation of P. obesus adipose tissue confirmed that chemerin was predominantly expressed in adipocytes, whereas CMKLR1 was expressed in both adipocytes and stromal-vascular cells of adipose tissue. In 3T3-L1 adipocytes, chemerin was markedly induced during differentiation, whereas CMKLR1 was down-regulated during differentiation. Serum chemerin levels were measured by ELISA in human plasma samples from 114 subjects with T2D and 142 normal glucose tolerant controls. Plasma chemerin levels were not significantly different between subjects with T2D and normal controls. However, in normal glucose tolerant subjects, plasma chemerin levels were significantly associated with body mass index, circulating triglycerides, and blood pressure. Here we report, for the first time, that chemerin is an adipokine, and circulating levels of chemerin are associated with several key aspects of metabolic syndrome.

    Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Publishing Authors By Initials

    k bozaogluK Bozaoglu,k boltonK Bolton,j mcmillanJ McMillan,p zimmetP Zimmet,j jowettJ Jowett,g collierG Collier,k walderK Walder,d segalD Segal,

    For similar body regions: viscera research abstracts see: body regions: viscera research

    PUBMED ID PMID:

    MEDLINE DATE:

    Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Endocrinology

    VOLUME: 148

    Page Numbers: 4687-94

    Journal Abbreviation: Endocrinology

    ISSN: 0013-7227

    DAY: 19

    MONTH: 07

    YEAR: 2007

    Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 375040

    Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Keywords Mesh Terms:

    KEYWORDS: Viscera

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Information

    Substance Name: chemerin, human

    Registry Number: 0

    Grant and Affiliation Information for Chemerin is a novel adipokine associated with obesity and metabolic syndrome.

    AFFILIATION: Metabolic Research Unit, School of Exercise and Nutrition Sciences, Deakin University, Pigdons Road, Waurn Ponds, Geelong, Victoria 3217, Australia.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIDDK

    GRANT: DK 25446

    ACRONYM: DK

    MEDLINETA: Endocrinology

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Chemerin is a novel adipokine associated with obesity and metabolic syndrome Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News